Diagnamed Holdings Corp. (CSE:DMED)

Diagnamed Holdings Income Statement

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cost of Revenue	-	-	-	-	0.02	0.02
Gross Profit	-	-	-	-	-0.02	-0.02
Selling, General & Admin	0.37	0.31	0.43	0.81	0.41	0.47
Research & Development	-0.07	0.05	0.25	0.35	0.56	0.2
Operating Expenses	1.27	1.41	0.67	1.18	1.11	0.67
Operating Income	-1.27	-1.41	-0.67	-1.18	-1.14	-0.68
Interest & Investment Income	0	0	0.01	0.01	-	-
Currency Exchange Gain (Loss)	0.01	-0.01	0.01	0.02	0	-
Other Non Operating Income (Expenses)	-0.09	-0.08	-0.07	-0.08	-	-
EBT Excluding Unusual Items	-1.34	-1.5	-0.72	-1.23	-1.13	-0.68
Other Unusual Items	0.1	0.1	0.22	-0.05	-	-1.26
Pretax Income	-1.25	-1.4	-0.5	-1.28	-1.13	-1.95
Net Income	-1.25	-1.4	-0.5	-1.28	-1.13	-1.95
Net Income to Common	-1.25	-1.4	-0.5	-1.28	-1.13	-1.95
Shares Outstanding (Basic)	110	93	80	78	76	56
Shares Outstanding (Diluted)	110	93	80	78	76	56
Shares Change (YoY)	35.41%	16.63%	2.38%	2.81%	36.38%	-
EPS (Basic)	-0.01	-0.02	-0.01	-0.02	-0.01	-0.03
EPS (Diluted)	-0.01	-0.02	-0.01	-0.02	-0.01	-0.03
EBIT	-1.27	-1.41	-0.67	-1.18	-1.14	-0.68

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 11, 2026

Data Sources Report a data error